Dolby Laboratories - DLB Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DLB shares.
View DLB analyst ratings or view top-rated stocks.

3 equities research analysts have issued twelve-month price objectives for Dolby Laboratories' stock. Their DLB share price forecasts range from $90.00 to $90.00. On average, they predict the company's stock price to reach $90.00 in the next year. This suggests a possible upside of 33.3% from the stock's current price.
View analysts price targets for DLB or view top-rated stocks among Wall Street analysts.

Dolby Laboratories' stock was trading at $95.22 at the start of the year. Since then, DLB stock has decreased by 29.1% and is now trading at $67.53.
View the best growth stocks for 2022 here.

Dolby Laboratories saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,040,000 shares, an increase of 11.9% from the August 31st total of 929,600 shares. Based on an average trading volume of 438,200 shares, the short-interest ratio is presently 2.4 days. Approximately 1.7% of the shares of the stock are sold short.
View Dolby Laboratories' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 15th 2022.
View our DLB earnings forecast.

Dolby Laboratories, Inc. (NYSE:DLB) released its earnings results on Tuesday, August, 9th. The electronics maker reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.05. The electronics maker earned $289.60 million during the quarter, compared to analyst estimates of $294.03 million. Dolby Laboratories had a net margin of 15.91% and a trailing twelve-month return on equity of 9.38%. The firm's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.52 EPS.

Dolby Laboratories announced a quarterly dividend on Tuesday, August 9th. Stockholders of record on Tuesday, August 23rd will be given a dividend of $0.25 per share on Wednesday, August 31st. This represents a $1.00 annualized dividend and a dividend yield of 1.48%. The ex-dividend date of this dividend is Monday, August 22nd.
Read our dividend analysis for DLB.

Dolby Laboratories (NYSE:DLB) pays an annual dividend of $1.00 per share and currently has a dividend yield of 1.50%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 51.55%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DLB will have a dividend payout ratio of 36.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DLB.

Dolby Laboratories updated its fourth quarter 2022 earnings guidance on Tuesday, September, 13th. The company provided earnings per share (EPS) guidance of $0.68-$0.83 for the period, compared to the consensus EPS estimate of $0.87. The company issued revenue guidance of $295.00 million-$325.00 million, compared to the consensus revenue estimate of $326.80 million.

253 employees have rated Dolby Laboratories Chief Executive Officer Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (4.02%), Clearbridge Investments LLC (3.19%), Mackenzie Financial Corp (1.43%), State Street Corp (1.09%), Wells Fargo & Company MN (1.07%) and Voya Investment Management LLC (0.74%). Insiders that own company stock include Avadis Tevanian, Emily Rollins, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay, Steven E Forshay and Todd Pendleton.
View institutional ownership trends.

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLB stock can currently be purchased for approximately $67.53.

Dolby Laboratories (NYSE:DLB) has a market capitalization of $6.81 billion and generates $1.28 billion in revenue each year. The electronics maker earns $310.23 million in net income (profit) each year or $1.94 on an earnings per share basis.

The company employs 2,368 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The official website for the company is www.dolby.com. The electronics maker can be reached via phone at (415) 558-0200, via email at investor@dolby.com, or via fax at 415-645-4000.